{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:51:08Z","timestamp":1788483068570,"version":"build-2803163510"},"reference-count":40,"publisher":"Society of Nuclear Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Nucl. Med.\n                Technol."],"accepted":{"date-parts":[[2026,3,1]]},"published-print":{"date-parts":[[2026,9]]},"DOI":"10.2967\/jnmt.125.271409","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T17:40:34Z","timestamp":1774978834000},"page":"309-317","source":"Crossref","is-referenced-by-count":1,"title":["Imaging Features That Predict Indeterminate Bone Lesion Outcomes on\n                    <sup>18<\/sup>\n                    F-DCFPyL PSMA PET\/CT Scan: A Multicenter Cohort of 42 Biopsy-Proven Lesions"],"prefix":"10.2967","volume":"54","author":[{"given":"Matthew S.","family":"Agritelley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bifei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan","family":"Linscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"Savas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"2026090306152277000_54.3.309.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2017.07.011"},{"key":"2026090306152277000_54.3.309.2","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-016-0957-6"},{"key":"2026090306152277000_54.3.309.3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s40291-021-00548-0","article-title":"Piflufolastat F18: diagnostic first approval","volume":"25","author":"Keam","year":"2021","journal-title":"Mol Diagn Ther."},{"key":"2026090306152277000_54.3.309.4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1148\/radiol.2021202771","article-title":"Prostate-specific membrane antigen PET in prostate cancer","volume":"299","author":"Lawhn-Heath","year":"2021","journal-title":"Radiology."},{"key":"2026090306152277000_54.3.309.5","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-015-0850-8"},{"key":"2026090306152277000_54.3.309.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.226381"},{"key":"2026090306152277000_54.3.309.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.226514"},{"key":"2026090306152277000_54.3.309.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.227793"},{"key":"2026090306152277000_54.3.309.9","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001698"},{"key":"2026090306152277000_54.3.309.10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4573"},{"key":"2026090306152277000_54.3.309.11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1148\/radiol.220218","article-title":"18F-DCFPyL PET\/CT for initially diagnosed and biochemically recurrent prostate cancer: prospective trial with pathologic confirmation","volume":"305","author":"Ulaner","year":"2022","journal-title":"Radiology."},{"key":"2026090306152277000_54.3.309.12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.juro.2017.07.070","article-title":"Prostate specific membrane antigen targeted 18F-DCFPyL positron emission tomography\/computerized tomography for the preoperative staging of high risk prostate cancer: results of a prospective, phase II, single center study","volume":"199","author":"Gorin","year":"2018","journal-title":"J Urol."},{"key":"2026090306152277000_54.3.309.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.231654"},{"key":"2026090306152277000_54.3.309.14","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ijrobp.2019.11.001","article-title":"A prospective study of 18F-DCFPyL PSMA PET\/CT restaging in recurrent prostate cancer following primary external beam radiotherapy or brachytherapy","volume":"106","author":"Liu","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2026090306152277000_54.3.309.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-035959"},{"key":"2026090306152277000_54.3.309.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.234799"},{"key":"2026090306152277000_54.3.309.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.217653"},{"key":"2026090306152277000_54.3.309.18","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1007\/s00259-021-05424-x","article-title":"Focal unspecific bone uptake on [18F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a potential pitfall in prostate cancer imaging","volume":"48","author":"Gr\u00fcnig","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026090306152277000_54.3.309.19","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00259-021-05655-y","article-title":"Staging 68Ga-PSMA PET\/CT in 963 consecutive patients with newly diagnosed prostate cancer: incidence and characterization of skeletal involvement","volume":"49","author":"Kesler","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026090306152277000_54.3.309.20","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-017-3780-7"},{"key":"2026090306152277000_54.3.309.21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1148\/rg.2018170108","article-title":"Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls","volume":"38","author":"Hofman","year":"2018","journal-title":"Radiographics."},{"key":"2026090306152277000_54.3.309.22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40644-020-00300-7","article-title":"Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings","volume":"20","author":"de Galiza Barbosa","year":"2020","journal-title":"Cancer Imaging."},{"key":"2026090306152277000_54.3.309.23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1148\/rg.2019180079","article-title":"Revisiting prostate cancer recurrence with PSMA PET: atlas of typical and atypical patterns of spread","volume":"39","author":"Barbosa","year":"2019","journal-title":"Radiographics."},{"key":"2026090306152277000_54.3.309.24","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267899"},{"key":"2026090306152277000_54.3.309.25","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00259-021-05245-y","article-title":"E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET","volume":"48","author":"Ceci","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026090306152277000_54.3.309.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.198119"},{"key":"2026090306152277000_54.3.309.27","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.195255"},{"key":"2026090306152277000_54.3.309.28","doi-asserted-by":"crossref","first-page":"e593","DOI":"10.1097\/RLU.0000000000002609","article-title":"Heterogeneity of 68Ga-PSMA PET\/CT uptake in fibrous dysplasia","volume":"44","author":"Plouznikoff","year":"2019","journal-title":"Clin Nucl Med."},{"key":"2026090306152277000_54.3.309.29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40644-018-0175-3","article-title":"68Ga-PSMA PET\/CT in prostate cancer patients: patterns of disease, benign findings and pitfalls","volume":"18","author":"Keidar","year":"2018","journal-title":"Cancer Imaging."},{"key":"2026090306152277000_54.3.309.30","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.2217\/fon-2018-0318","article-title":"Narrative medicine in metastatic prostate cancer reveals ways to improve patient awareness & quality of care","volume":"14","author":"De Vincentis","year":"2018","journal-title":"Future Oncol."},{"key":"2026090306152277000_54.3.309.31","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1007\/s00259-021-05456-3","article-title":"Clinical insignificance of [18F]PSMA-1007 avid non-specific bone lesions: a retrospective evaluation","volume":"48","author":"Arnfield","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026090306152277000_54.3.309.32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13550-020-00745-8","article-title":"The significance of equivocal bone findings in staging PSMA imaging in the preoperative setting: validation of the PSMA-RADS version 1.0","volume":"11","author":"Kuten","year":"2021","journal-title":"EJNMMI Res."},{"key":"2026090306152277000_54.3.309.33","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.229187"},{"key":"2026090306152277000_54.3.309.34","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/bju.15152","article-title":"Solitary rib lesions showing PSMA uptake in pre-treatment staging 68Ga-PSMA-11 positron emission tomography scans for men with prostate cancer: benign or malignant?","volume":"126","author":"Chen","year":"2020","journal-title":"BJU Int."},{"key":"2026090306152277000_54.3.309.35","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264334"},{"key":"2026090306152277000_54.3.309.36","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00605-2"},{"key":"2026090306152277000_54.3.309.37","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.233460"},{"key":"2026090306152277000_54.3.309.38","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1007\/s00261-024-04738-2","article-title":"PSMA-RADS to improve evaluation and management of prostate cancer","volume":"50","author":"Rafiei Alavi","year":"2025","journal-title":"Abdom Radiol (NY)."},{"key":"2026090306152277000_54.3.309.39","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.crad.2023.12.008","article-title":"Fluorine-18 prostate-specific membrane antigen-1007-avid indeterminate bone lesions in prostate cancer: clinical and PET\/CT features to predict outcomes and prognosis","volume":"79","author":"Luo","year":"2024","journal-title":"Clin Radiol."},{"key":"2026090306152277000_54.3.309.40","doi-asserted-by":"crossref","first-page":"e529","DOI":"10.1097\/RLU.0000000000004259","article-title":"Bone uptake in prostate cancer patients: diagnostic performances of PSMA-RADS v1.0, clinical, biological, and 68Ga-PSMA-11 PET features to predict metastasis after biochemical recurrence","volume":"47","author":"Letang","year":"2022","journal-title":"Clin Nucl Med."}],"container-title":["Journal of Nuclear Medicine Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnmt.125.271409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:16:09Z","timestamp":1788441369000},"score":1,"resource":{"primary":{"URL":"http:\/\/tech.snmjournals.org\/lookup\/doi\/10.2967\/jnmt.125.271409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9,3]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.2967\/jnmt.125.271409"],"URL":"https:\/\/doi.org\/10.2967\/jnmt.125.271409","relation":{},"ISSN":["0091-4916","1535-5675"],"issn-type":[{"value":"0091-4916","type":"print"},{"value":"1535-5675","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]}}}